Karin Eastham insider trades
Open-market stock purchases and sales by Karin Eastham, Director at Veracyte, Inc, from SEC Form 4 filings since Mar 2, 2010.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 18, 2026 | VCYT Veracyte, Inc | Sold | $169K |
| Jun 18, 2026 | VCYT Veracyte, Inc | Sold | $28.3K |
| Jun 11, 2026 | VCYT Veracyte, Inc | Bought (not open market) | — |
| May 12, 2026 | PSNL Personalis, Inc | Bought (not open market) | — |
| May 12, 2026 | PSNL Personalis, Inc | Bought (not open market) | — |
| May 12, 2026 | PSNL Personalis, Inc | Bought (not open market) | — |
| Dec 5, 2025 | VCYT Veracyte, Inc | Sold | $285K |
| Dec 5, 2025 | VCYT Veracyte, Inc | Sold | $587K |
| Dec 5, 2025 | VCYT Veracyte, Inc | Sold | $37.3K |
| Dec 5, 2025 | VCYT Veracyte, Inc | Bought (not open market) | — |
| Nov 5, 2025 | VCYT Veracyte, Inc | Sold | $387K |
Companies traded
- VCYT Veracyte, Inc: 32 sales, last Jun 18, 2026
- PSNL Personalis, Inc: other filings, last May 12, 2026
- GERN Geron Corp: other filings, last Jan 13, 2023
- NKTR Nektar Therapeutics: 1 sale, last Sep 16, 2022
- ILMN Illumina Inc: 64 sales, last May 23, 2019
- TSRX Trius Therapeutics Inc: other filings, last Sep 11, 2013
- AMLN Amylin Pharmaceuticals Inc: other filings, last Aug 8, 2012
- GXDX Genoptix Inc: other filings, last Mar 4, 2011